Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer
To access this article, please choose from the options below
PII: S0169-5002(09)00107-X
doi:10.1016/j.lungcan.2009.02.009
© 2009 Elsevier Ireland Ltd. All rights reserved.
